about
Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinomaIndole-3-carbinol (I3C) increases apoptosis, represses growth of cancer cells, and enhances adenovirus-mediated oncolysisConditionally replicating adenovirus expressing TIMP2 increases survival in a mouse model of disseminated ovarian cancerVSV-tumor selective replication and protein translation.Replicating parvoviruses that target colon cancer cellsMethods for screening tumors for p53 status and therapeutic exploitation.Cancer gene therapy: an awkward adolescence.Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer.Meeting product development challenges in manufacturing clinical grade oncolytic adenoviruses.Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational controlOncolytic adenoviruses as antiglioma agents.Oncolytic virotherapy for malignant glioma: translating laboratory insights into clinical practice.Role of transforming growth factor-beta in cancer progression.Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors.Oncolytic viruses in the treatment of cancer: a review of current strategies.Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme.Oncolytic viral therapy for neuroblastoma cells with Sindbis virus AR339 strain.Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.Comparison of the E3 and L3 regions for arming oncolytic adenoviruses to achieve a high level of tumor-specific transgene expression.Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells.Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.Bcl-2 and Bcl-x(L) differentially protect human prostate cancer cells from induction of apoptosis by melanoma differentiation associated gene-7, mda-7/IL-24.Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro.Combined treatment of pediatric high-grade glioma with the oncolytic viral strain MTH-68/H and oral valproic acid.Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model.Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy.
P2860
Q33868732-F0B91D69-F7A0-4A0E-B379-CD3733B64539Q34028482-66593F4B-CCB3-4162-A37F-D953E1442800Q34055529-3CE59C01-6F0F-4151-AD54-832070471699Q34651274-ABD96E73-C564-49F8-AAF2-E35C39EA8DEFQ35020290-C35AE809-1B1D-48E8-86B8-BCA77CD30DFEQ35142162-90E69D9B-017F-4CF1-B33C-36A8161D6DAAQ35165726-653BAF4F-D008-4EEA-AA60-E87FF26141B8Q36318166-2CD6FFB4-FD91-44E4-A82F-69299DCF7608Q36318198-FE1BFCCA-2904-4180-99C1-F558F83E53B5Q36498617-F18714DD-3BEB-49E3-9C23-462EDA451603Q36499227-142E3045-2BF2-4337-A569-ECC2AE072C9AQ36634430-E8FF9E54-D085-4568-8B75-3F9AD962D800Q36677493-5EEC6E79-0B0E-4761-A361-10B034AABDBEQ37145300-2EE3D5C7-B8A2-4540-B1E2-B69B61F2F444Q38020107-1EF847E1-E62A-467B-B414-6456EB0DDB87Q38253056-B389AEEC-6277-4730-B622-A2467EA209F6Q38841695-24C098AB-D5CB-40A9-B357-D5B0AE140F25Q40018751-7B48300B-A18E-4805-8A1D-EAFE47ECB0B1Q40081527-47C108D3-48CD-4A77-8DAC-0F1A5DA9298EQ40341364-F6A75241-CA54-4693-A0A8-5F0831CEC60BQ40598798-3CDD48EF-3B30-4738-B099-6C6577308018Q40611422-D2252776-6173-466D-AE5E-833169809D49Q42202353-55BE8521-8E43-4B37-B781-94DAA7B6789EQ44135421-0CED4DD7-0F47-46B7-BA38-1F12D9DA74EBQ45864115-867A7B2B-C8A4-4756-AFC6-9EB13E60DB43Q45864761-B531646E-40C0-487E-91EA-047A8FC21401
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Replication-selective viruses for cancer therapy.
@ast
Replication-selective viruses for cancer therapy.
@en
Replication-selective viruses for cancer therapy.
@nl
type
label
Replication-selective viruses for cancer therapy.
@ast
Replication-selective viruses for cancer therapy.
@en
Replication-selective viruses for cancer therapy.
@nl
prefLabel
Replication-selective viruses for cancer therapy.
@ast
Replication-selective viruses for cancer therapy.
@en
Replication-selective viruses for cancer therapy.
@nl
P2093
P1476
Replication-selective viruses for cancer therapy.
@en
P2093
Carola Biederer
Christian H Brandts
Frank McCormick
Stefan Ries
P2888
P304
P356
10.1007/S00109-001-0295-1
P577
2001-12-20T00:00:00Z
P6179
1052798902